UCLA researchers have recently published a finding that they suggests may be the key to reversing memory loss and altering the way we administer Alzheimer's care:
Alzheimer's disease was first recognized about 100 years ago, and there is still no treatment that has proven to be effective against the progression of the disease. These UCLA researchers are claiming that they have developed a simple program that reverses the debilitating symptoms of the disease. The program is completely novel, and is a comprehensive, personalized program for people suffering with Alzheimer's and requiring dementia care.
More and more studies are pointing to the importance of diet in our overall health. Many doctors and researchers are now emphatically stating that the majority of our major causes of death are preventable and reversible. In fact, we are eating ourselves to death. The culprit?...sugar and simple carbohydrates.
The basic assumptions in this study rely on the notion of the plasticity of the brain. That is to say, that the brain can heal itself, even create new neural connections and pathways, thus leading to improved cognition and memory function. This plasticity stays with us until we die. This means we can keep learning and improving our minds through our entire lives.
The UCLA researchers point out that diet, sleep, and exercise have a profound effect on Alzheimer's disease. These all impact the plasticity of our brains. In the UCLA study, ten patients made dramatic therapeutic lifestyle changes, virtually eliminating, sugar, simple carbs (like flour, rice, and potatoes), and all processed foods. They supplemented this dietary change with fish oil, vitamin D3, vitamin B12, melatonin, and took yoga and meditated. Two and a half years later, after six of the patients were able to return to work, the beneficial effects of the lifestyle changes remained. The conclusion is that cognition and memory can be changed by altering our metabolic processes, although they do point out that in this study that the results are anecdotal and full clinical trials are needed.
The full research paper can be viewed here: http://impactaging.com/papers/v6/n9/full/100690.html
Dale E. Bredesen1, 2
1 Mary S. Easton Center for Alzheimer's Disease Research, Department of Neurology, University of California, Los Angeles, CA 90095;
2 Buck Institute for Research on Aging, Novato, CA 94945.
Alzheimer's, dementia, mild cognitive impairment, neurobehavioral disorders, neuroinflammation, neurodegeneration, systems biology
9/15/14; Accepted: 9/26/14; Published: 9/27/14
Dale E. Bredesen, MD; E-mail: firstname.lastname@example.org;email@example.com